- Home
- STRR vs GNPX Comparison
STRR vs GNPX Comparison
Compare STRR & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRR
- GNPX
- Stock Information
- Founded
- STRR 1985
- GNPX 2009
- Country
- STRR United States
- GNPX United States
- Employees
- STRR N/A
- GNPX N/A
- Industry
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GNPX Biotechnology: Pharmaceutical Preparations
- Sector
- STRR Health Care
- GNPX Health Care
- Exchange
- STRR Nasdaq
- GNPX Nasdaq
- Market Cap
- STRR 7.0M
- GNPX 6.1M
- IPO Year
- STRR N/A
- GNPX 2018
- Fundamental
- Price
- STRR $2.19
- GNPX $0.39
- Analyst Decision
- STRR
- GNPX Strong Buy
- Analyst Count
- STRR 0
- GNPX 1
- Target Price
- STRR N/A
- GNPX $10.00
- AVG Volume (30 Days)
- STRR 6.2K
- GNPX 1.5M
- Earning Date
- STRR 03-21-2025
- GNPX 03-31-2025
- Dividend Yield
- STRR N/A
- GNPX N/A
- EPS Growth
- STRR N/A
- GNPX N/A
- EPS
- STRR N/A
- GNPX N/A
- Revenue
- STRR $50,375,000.00
- GNPX N/A
- Revenue This Year
- STRR $15.58
- GNPX N/A
- Revenue Next Year
- STRR $36.27
- GNPX N/A
- P/E Ratio
- STRR N/A
- GNPX N/A
- Revenue Growth
- STRR 2.22
- GNPX N/A
- 52 Week Low
- STRR $2.05
- GNPX $0.28
- 52 Week High
- STRR $5.35
- GNPX $5.41
- Technical
- Relative Strength Index (RSI)
- STRR 49.56
- GNPX 23.70
- Support Level
- STRR $2.10
- GNPX $0.38
- Resistance Level
- STRR $2.23
- GNPX $0.55
- Average True Range (ATR)
- STRR 0.10
- GNPX 0.05
- MACD
- STRR 0.02
- GNPX 0.00
- Stochastic Oscillator
- STRR 63.64
- GNPX 12.78
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.
About GNPX Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.